Mosdósi B et al. |
Severe acrocyanosis precipitated by cold agglutinin secondary to infection with Mycoplasma pneumoniae in a pediatric patient. |
2017 |
Croat. Med. J. |
pmid:29308834
|
Zhang X and Hu C |
Selecting optimal columns for clarithromycin impurity analysis according to the quantitative relationship of hydrophobic subtraction model. |
2017 |
J Pharm Biomed Anal |
pmid:28024686
|
Addo KK et al. |
Genotyping and drug susceptibility testing of mycobacterial isolates from population-based tuberculosis prevalence survey in Ghana. |
2017 |
BMC Infect. Dis. |
pmid:29197331
|
Liu W et al. |
Rapid detection of mutations in erm(41) and rrl associated with clarithromycin resistance in Mycobacterium abscessus complex by denaturing gradient gel electrophoresis. |
2017 |
J. Microbiol. Methods |
pmid:29079298
|
Koh WJ et al. |
Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease. |
2017 |
Clin. Infect. Dis. |
pmid:28011608
|
Chang CH et al. |
Non-Tuberculous Mycobacteria Infection Following Autologous Fat Grafting on the Face. |
2017 |
Aesthet Surg J |
pmid:29045552
|
Çekin AH et al. |
Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance. |
2017 |
Turk J Gastroenterol |
pmid:28007678
|
Ikeue T et al. |
Pleuritis Caused by Mycobacterium kyorinense without Pulmonary Involvement. |
2017 |
Intern. Med. |
pmid:28924121
|
Yamamoto S et al. |
Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production. |
2017 |
Biochem. Biophys. Res. Commun. |
pmid:27998764
|
Panozzo C et al. |
Chemicals or mutations that target mitochondrial translation can rescue the respiratory deficiency of yeast bcs1 mutants. |
2017 |
Biochim. Biophys. Acta |
pmid:28888990
|
Santos MA et al. |
Nothing to (S)cough at: Pulmonary Mycobacterium avium Complex Infection. |
2017 |
Am. J. Med. |
pmid:27984010
|
Smibert OC et al. |
Short Communication: Mycobacterium avium Complex Infection and Immune Reconstitution Inflammatory Syndrome Remain a Challenge in the Era of Effective Antiretroviral Therapy. |
2017 |
AIDS Res. Hum. Retroviruses |
pmid:28791872
|
Hiroi S et al. |
Impact of health insurance coverage for gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data. |
2017 |
BMJ Open |
pmid:28760790
|
Jenkins H et al. |
Effect of Multiple Oral Doses of the Potent CYP3A4 Inhibitor Clarithromycin on the Pharmacokinetics of a Single Oral Dose of Vonoprazan: A Phase I, Open-Label, Sequential Design Study. |
2017 |
Clin Drug Investig |
pmid:27928738
|
Takemoto Y et al. |
Disseminated Mycobacterium scrofulaceum Infection in an Immunocompetent Host. |
2017 |
Intern. Med. |
pmid:28717096
|
Alba C et al. |
Antibiotic resistance in Helicobacter pylori. |
2017 |
Curr. Opin. Infect. Dis. |
pmid:28704226
|
Mishima E et al. |
Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole. |
2017 |
Intern. Med. |
pmid:28674358
|
Sun W et al. |
Synergistic drug combination effectively blocks Ebola virus infection. |
2017 |
Antiviral Res. |
pmid:27890675
|
Shimoyama T et al. |
Randomized Trial Comparing Esomeprazole and Rabeprazole in First-line Eradication Therapy for Helicobacter pylori Infection based on the Serum Levels of Pepsinogens. |
2017 |
Intern. Med. |
pmid:28674348
|
Hung IFN et al. |
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial. |
2017 |
Chest |
pmid:27884765
|
Ustundag GH et al. |
The Effects of Synbiotic " B94 plus Inulin" Addition on Standard Triple Therapy of Eradication in Children. |
2017 |
Can J Gastroenterol Hepatol |
pmid:28656129
|
Peng X et al. |
Gastric Juice-Based Real-Time PCR for Tailored Treatment: A Practical Approach. |
2017 |
Int J Med Sci |
pmid:28638276
|
Ozturk O et al. |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication. |
2017 |
Arab J Gastroenterol |
pmid:28601610
|
Aguilera-Correa JJ et al. |
Detection of Helicobacter pylori and the genotypes of resistance to clarithromycin and the heterogeneous genotype to this antibiotic in biopsies obtained from symptomatic children. |
2017 |
Diagn. Microbiol. Infect. Dis. |
pmid:27863951
|
Alirezaei A et al. |
Helicobacter pylori Eradication With Levofloxacin or Clarithromycin in Dialysis Versus Nonuremic Patients. |
2017 |
Iran J Kidney Dis |
pmid:28575885
|
Cosme A et al. |
Antimicrobial susceptibility testing before first-line treatment for infection in patients with dual or triple antibiotic resistance. |
2017 |
World J. Gastroenterol. |
pmid:28566898
|
Angol DC et al. |
from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool. |
2017 |
Biomed Res Int |
pmid:28555193
|
Stieler Stewart AL et al. |
Effects of clarithromycin, azithromycin and rifampicin on terbutaline-induced sweating in foals. |
2017 |
Equine Vet. J. |
pmid:28238211
|
Geng X et al. |
The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28242673
|
Emmanuel R et al. |
Antimicrobial efficacy of drug blended biosynthesized colloidal gold nanoparticles from Justicia glauca against oral pathogens: A nanoantibiotic approach. |
2017 |
Microb. Pathog. |
pmid:29101061
|
Larsen EL et al. |
Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials. |
2017 |
Br J Clin Pharmacol |
pmid:28185274
|
Ono S et al. |
Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin. |
2017 |
Helicobacter |
pmid:28098408
|
Bichler EK et al. |
Clarithromycin increases neuronal excitability in CA3 pyramidal neurons through a reduction in GABAergic signaling. |
2017 |
J. Neurophysiol. |
pmid:27733592
|
Gouin-Thibault I et al. |
Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin. |
2017 |
J. Thromb. Haemost. |
pmid:27893182
|
Tsugawa K et al. |
Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells. |
2017 |
Clin. Exp. Nephrol. |
pmid:27614743
|
Ivanová L et al. |
Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka. |
2017 |
Environ. Res. |
pmid:28183039
|
Varma MV et al. |
Transporter-Mediated Hepatic Uptake Plays an Important Role in the Pharmacokinetics and Drug-Drug Interactions of Montelukast. |
2017 |
Clin. Pharmacol. Ther. |
pmid:27648490
|
Huet D et al. |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. |
2017 |
Rev Mal Respir |
pmid:27639948
|
El Haj C et al. |
The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance? |
2017 |
Med. Microbiol. Immunol. |
pmid:27639707
|
Jia L et al. |
Synthesis and antibacterial evaluation of novel 11-O-carbamoyl clarithromycin ketolides. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28711353
|
Park J et al. |
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense. |
2017 |
Clin. Infect. Dis. |
pmid:28011609
|
Park SM et al. |
Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection. |
2017 |
J. Gastroenterol. Hepatol. |
pmid:27505301
|
Ishiguro N et al. |
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients. |
2017 |
PLoS ONE |
pmid:28288170
|
Attaran B et al. |
Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. |
2017 |
World J. Gastroenterol. |
pmid:28275296
|
Seyama S et al. |
Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A). |
2017 |
J. Antimicrob. Chemother. |
pmid:27999037
|
Zerbetto De Palma G et al. |
Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City. |
2017 |
Microb. Drug Resist. |
pmid:27391421
|
Okuda M et al. |
Nationwide survey of Helicobacter pylori treatment for children and adolescents in Japan. |
2017 |
Pediatr Int |
pmid:27223686
|
Bewick J et al. |
The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis. |
2017 |
Clin Otolaryngol |
pmid:27223120
|
Legendre T et al. |
[Antibiomania: Think of the manic syndrome secondary to antibiotic therapy]. |
2017 |
Encephale |
pmid:27178256
|
Choi HS et al. |
Peritoneal Dialysis-Related Peritonitis Caused by Microbacterium paraoxydans. |
2017 |
Jpn. J. Infect. Dis. |
pmid:27169951
|
Serrano CA et al. |
Helicobacter pylori-Clarithromycin Resistance in Symptomatic Pediatric Patients in a High Prevalence Country. |
2017 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:27159208
|
Osaki T et al. |
Usefulness of detection of clarithromycin-resistant Helicobacter pylori from fecal specimens for young adults treated with eradication therapy. |
2017 |
Helicobacter |
pmid:28544222
|
Chang CT et al. |
Antibiotic treatment of zebrafish mycobacteriosis: tolerance and efficacy of treatments with tigecycline and clarithromycin. |
2017 |
J. Fish Dis. |
pmid:28422304
|
Furuya H et al. |
SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. |
2017 |
Rheumatology (Oxford) |
pmid:28371927
|
Ye JF et al. |
Evaluation of first-line bismuth-containing 7-day concomitant quintuple therapy for Helicobacter pylori eradication. |
2017 |
J Dig Dis |
pmid:29119724
|
Chang KH et al. |
Comparison of antibiotic regimens in preterm premature rupture of membranes: neonatal morbidity and 2-year follow-up of neurologic outcome. |
2017 |
J. Matern. Fetal. Neonatal. Med. |
pmid:27687157
|
Abadi ATB |
Resistance to clarithromycin and gastroenterologist's persistence roles in nomination for Helicobacter pylori as high priority pathogen by World Health Organization. |
2017 |
World J. Gastroenterol. |
pmid:29085187
|
Pastukh N et al. |
GenoType® HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones. |
2017 |
Helicobacter |
pmid:29058343
|
Tognetti L et al. |
Bullous impetigo during interstitial pneumonitis. |
2017 |
G Ital Dermatol Venereol |
pmid:29050448
|
Chen MJ et al. |
Impact of amoxicillin resistance on the efficacy of amoxicillin-containing regimens for Helicobacter pylori eradication: analysis of five randomized trials. |
2017 |
J. Antimicrob. Chemother. |
pmid:28961996
|
Kim SY et al. |
Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea. |
2017 |
Helicobacter |
pmid:28940815
|
Mukherjee D et al. |
Vancomycin and Clarithromycin Show Synergy against . |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923867
|
Sotto RB et al. |
Sub-lethal pharmaceutical hazard tracking in adult zebrafish using untargeted LC-MS environmental metabolomics. |
2017 |
J. Hazard. Mater. |
pmid:28623724
|
Liatsos C and Leontiadis GII |
The "report card" to grade H. Pylori treatment regimens: is it achievable in real-world in areas with high clarithromycin resistance? |
2017 |
J Gastrointestin Liver Dis |
pmid:28617893
|
Chew CA et al. |
The diagnosis and management of H. pylori infection in Singapore. |
2017 |
Singapore Med J |
pmid:28536725
|
Gunnarsdottir AI et al. |
Antibiotic susceptibility of Helicobacter pylori in Iceland. |
2017 |
Infect Dis (Lond) |
pmid:28440099
|
Manniello MD et al. |
Clarithromycin and N-acetylcysteine co-spray-dried powders for pulmonary drug delivery: A focus on drug solubility. |
2017 |
Int J Pharm |
pmid:28377314
|
Van der Paardt AL et al. |
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. |
2017 |
Eur. Respir. J. |
pmid:28331034
|
Souto Filho JTD et al. |
Long-term complete remission of primary gastric plasmacytoma following endoscopic resection. |
2017 |
Ann. Hematol. |
pmid:28315923
|
Antonakos N et al. |
Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome. |
2017 |
Crit Care |
pmid:28274246
|
Koratala A et al. |
Exit Site Infection in Peritoneal Dialysis; Need for Follow-Up on Cultures Despite Clinical Improvement. |
2017 |
Blood Purif. |
pmid:28268216
|
Lin CM et al. |
Is ionizing radiation a risk factor to diffuse panbronchiolitis? |
2017 |
QJM |
pmid:28069906
|
Carneiro MDS et al. |
Lack of association between rrl and erm(41) mutations and clarithromycin resistance in Mycobacterium abscessus complex. |
2017 |
Mem. Inst. Oswaldo Cruz |
pmid:29091138
|
Oikawa R et al. |
Enrichment of Helicobacter pylori mutant strains after eradication therapy analyzed by gastric wash-based quantitative pyrosequencing. |
2017 |
Tumour Biol. |
pmid:28990461
|
Radzikowska E et al. |
Cryptogenic organizing pneumonia-Results of treatment with clarithromycin versus corticosteroids-Observational study. |
2017 |
PLoS ONE |
pmid:28945804
|
Chew KL et al. |
Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital. |
2017 |
J. Med. Microbiol. |
pmid:28874233
|
Miura S et al. |
[Effective BiRd Therapy after the Addition of Clarithromycin for Lenalidomide and Dexamethasone Resistant Multiple Myeloma Ineligible for Stem Cell Transplantation]. |
2017 |
Gan To Kagaku Ryoho |
pmid:28860442
|
McCallum GB et al. |
Antibiotics for persistent cough or wheeze following acute bronchiolitis in children. |
2017 |
Cochrane Database Syst Rev |
pmid:28828759
|
de Ãvila BE et al. |
Micromotor-enabled active drug delivery for in vivo treatment of stomach infection. |
2017 |
Nat Commun |
pmid:28814725
|
Zhang D et al. |
Berberine containing quadruple therapy for initial Helicobacter pylori eradication: An open-label randomized phase IV trial. |
2017 |
Medicine (Baltimore) |
pmid:28796053
|
Fraser AG |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776748
|
Jung YS et al. |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776746
|
Makihara K et al. |
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients. |
2017 |
Cancer Chemother. Pharmacol. |
pmid:28711984
|
Tanabe H et al. |
Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature. |
2017 |
Dig. Dis. Sci. |
pmid:28664410
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Sue S et al. |
The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication. |
2017 |
Intern. Med. |
pmid:28566587
|
Anwar HF et al. |
Synthesis of clarithromycin ketolides chemically modified at the unreactive C10-methyl group. |
2017 |
Bioorg. Med. Chem. |
pmid:28302508
|
Turvey SL et al. |
Mycobacterium branderi infection: Case report and literature review of an unusual and difficult-to-treat non-tuberculous mycobacterium. |
2017 |
Int. J. Infect. Dis. |
pmid:28268125
|
Kadota JI et al. |
The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study. |
2017 |
J. Infect. Chemother. |
pmid:28254517
|
Ufuk A et al. |
In Vitro and in Silico Tools To Assess Extent of Cellular Uptake and Lysosomal Sequestration of Respiratory Drugs in Human Alveolar Macrophages. |
2017 |
Mol. Pharm. |
pmid:28252969
|
Iwayama K et al. |
Long-term treatment of clarithromycin at a low concentration improves hydrogen peroxide-induced oxidant/antioxidant imbalance in human small airway epithelial cells by increasing Nrf2 mRNA expression. |
2017 |
BMC Pharmacol Toxicol |
pmid:28235416
|
Komiya K et al. |
Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts. |
2017 |
Respir. Res. |
pmid:28219384
|
Sakurai K et al. |
Comparative study: Vonoprazan and proton pump inhibitors in eradication therapy. |
2017 |
World J. Gastroenterol. |
pmid:28216974
|
Awan S et al. |
Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study. |
2017 |
Lung Cancer |
pmid:28213005
|
Su J et al. |
Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial. |
2017 |
Medicine (Baltimore) |
pmid:28207505
|
Branquinho D et al. |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics? |
2017 |
BMC Gastroenterol |
pmid:28202013
|
Inukai K et al. |
Effect of gel formation on the dissolution behavior of clarithromycin tablets. |
2017 |
Int J Pharm |
pmid:28196716
|
Miftahussurur M et al. |
Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Infection in the Dominican Republic. |
2017 |
Am. J. Trop. Med. Hyg. |
pmid:28193745
|
Zhang Z et al. |
In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense. |
2017 |
Int. J. Antimicrob. Agents |
pmid:28188830
|
Quinn KL et al. |
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study. |
2017 |
Drug Saf |
pmid:28421551
|